Strumento inattivo

Azioni King Pharmaceuticals, Inc.

Azioni

Prezzo di chiusura Nyse Altri mercati azionari
- ^USD	-

KING PHARMA : King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets	20/12/10
KING PHARMA : The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of King Pharmaceuticals, Inc. in Connection with the Sale of the Company to Pfizer, Inc. – KG	13/10/10
KING PHARMA : Law Office of Brodsky & Smith, LLC Announces Investigation of King Pharmaceuticals	13/10/10
KING PHARMA : Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of King Pharmaceuticals, Inc.	13/10/10
KING PHARMA : Ryan & Maniskas, LLP Announces Investigation of King Pharmaceuticals Inc.	12/10/10

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+16,71%	44,48 Mrd
LONZA GROUP AG	+43,74%	40,57 Mrd
IQVIA HOLDINGS INC.	-7,92%	38,82 Mrd
ALNYLAM PHARMACEUTICALS, INC.	+33,09%	32,22 Mrd
CELLTRION, INC.	-7,10%	27,84 Mrd
ICON PUBLIC LIMITED COMPANY	+14,46%	26,79 Mrd
UNITED THERAPEUTICS CORPORATION	+46,73%	14,31 Mrd
MEDPACE HOLDINGS, INC.	+34,07%	12,7 Mrd
BIO-TECHNE CORPORATION	-7,61%	11,23 Mrd